BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
We would like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on June 16, 2022 has approved the allotment of 46,000 equity shares of face value of Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan 2019 ('Bliss GVS ESOP-2019'). BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Vibha Gagan Sharma & PACs BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Vibha Gagan Sharma & PACs BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper advertisements pertaining to Notice of 37th Annual General Meeting of the Company scheduled to be held on Tuesday, June 28, 2022 at 11:00 a.m. (IST) through Video Conferencing/Other Audio Visual Means, e-Voting details and Book Closure information. BLISS GVS PHARMA LTD. - 506197 - Intimation Of Record Date For The Purpose Of Final Dividend For The Financial Year Ended March 31, 2022
Pursuant to Regulation 42 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') and in continuation to our intimated details on April 30, 2022 relating to Book Closure, please note that Bliss GVS Pharma Limited ('the Company') has fixed Tuesday, June 21, 2022 as the Record Date for determining entitlement of members to Final Dividend for the financial year ended on March 31, 2022. Payment of Dividend, subject to approval of the members at the ensuing AGM, will be made on or after Wednesday, June 29, 2022. BLISS GVS PHARMA LTD. - 506197 - Reg. 34 (1) Annual Report.
Pursuant to Regulation 34(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), please find enclosed Notice Convening the 37th AGM and the Annual Report of the Company for the financial year 2021-22. BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Pursuant to Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015, this is to inform you that, Mr. Vipul B. Thakkar has tendered his resignation from the position of Chief Financial Officer ("CFO") of the Company due to his personal reasons. Mr. Vipul B. Thakkar will continue to be with the Company till closing of business hours of June 30, 2022. BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the shareholder. BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Vibha Gagan Sharma & PACs BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Vibha Gagan Sharma & PACs